NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
NEW YORK (Reuters Health) – When sepsis is suspected in a newborn infant, a complete blood count as a test for infection improves “dramatically” with increasing time over…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – The hope of finding a way to quickly measure carboxyhemoglobin levels in suspected carbon monoxide poisoning is still unfulfilled, it seems. The Rad-57…
NEW YORK (Reuters Health) – Among women treated for endometrial hyperplasia, regression rates appear to be better with the levonorgestrel-releasing intrauterine system than with oral progestogen treatment, according…
NEW YORK (Reuters Health) – Percutaneous revascularization of the left main coronary artery can be performed via the transradial approach, with success rates similar to transfemoral access, according…
NEW YORK (Reuters Health) – In terms of efficacy and safety, low-molecular weight heparin is better than unfractionated heparin in the treatment of patients presenting with cerebral venous…
